Abbas Hussain - 14 Jun 2021 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
16 Jun 2021, 08:18:22 UTC
Next SEC filing
12 Feb 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Dov Bergwerk as attorney-in-fact for Abbas Hussain

Key filing fact

Abbas Hussain filed Form 4 for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) on 16 Jun 2021.

Key facts

  • This page summarizes Abbas Hussain's Form 4 filing for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 16 Jun 2021, 08:18.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TEVA transaction Derivative

Restricted Share Units

Award

Transaction value
$0
Shares
+14,479
Change %
Price
$0.000000
Shares after
14,479
Date
14 Jun 2021
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
14,479
Exercise price
Footnotes
F1, F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.

Footnote F2

Restricted share units were granted on June 14, 2021 and vest on June 14, 2022.

Footnote F3

The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .